CUREXIME CV Dry Syrup contains Cefixime and Potassium Clavulanate in a pediatric-friendly formulation designed to treat resistant bacterial infections in children. Cefixime, a third-generation cephalosporin, inhibits bacterial cell wall synthesis, while Clavulanate acts as a beta-lactamase inhibitor, protecting the antibiotic from enzymatic degradation. This combination provides extended-spectrum coverage and is commonly used in respiratory tract infections, ENT infections, urinary tract infections, and other pediatric bacterial conditions.
Composition
- Cefixime 50 mg
- Potassium Clavulanate 31.25 mg
- (per 5 ml after reconstitution)
Key Features & Benefits
- Beta-Lactamase Protection: Effective against resistant organisms
- Extended Spectrum Coverage: Targets a wide range of pathogens
- Pediatric-Friendly Formulation: Easy-to-administer oral suspension
- Effective in Resistant Infections: Suitable where standard therapy may fail
- Improved Compliance: Palatable and convenient dosing
Recommended Usage
- To be taken as prescribed by a healthcare professional
- Reconstitute with boiled and cooled water up to the mark
- Shake well before each use
- Complete the full course as advised
Safety Information
- Not recommended in patients with hypersensitivity to cephalosporins or beta-lactam antibiotics
- Use cautiously in patients with liver or kidney disorders
- Store as advised after reconstitution and use within prescribed duration
- Do not exceed the recommended dose
Storage Instructions
- Store in a cool, dry place before reconstitution
- After reconstitution, keep as advised and use within prescribed duration
- Protect from direct sunlight
- Keep out of reach of children
